Kombiglyze (saxagliptin recalls
The FDA has published 2 recalls involving Kombiglyze (saxagliptin since 2012. The latest was reported on 31 Oct 2012. Most were for labeling errors. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2012
Last 12 months0reported
Class I00% of total
Ongoing0latest 31 Oct 2012
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why kombiglyze (saxagliptin is recalled
Companies
By year
All kombiglyze (saxagliptin recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Kombiglyze XR (saxagliptin and metformin HCl recalled | Bristol-myers Squibb | Labeling Errors | Nationwide |
| Drug | CLASS II | Kombiglyze XR (saxagliptin and metformin HCl recalled | Bristol-myers Squibb | Labeling Errors | Nationwide |
Should you stop taking Kombiglyze (saxagliptin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.